SiegelRL, MillerKD, Goding SauerA, et al.Colorectal cancer statistics, 2020. CA Cancer J Clin, 2020; 70:145–164.
2.
MentellaMC, ScaldaferriF, RicciC, et al.Cancer and Mediterranean diet: A review. Nutrients, 2019; 11:2059.
3.
SongM, ChanAT, SunJ. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology, 2020; 158:322–340.
4.
AleksandrovaK, Romero-MosqueraB, HernandezV. Diet, gut microbiome and epigenetics: Emerging links with inflammatory bowel diseases and prospects for management and prevention. Nutrients, 2017; 9:1–13.
5.
MahmoudAM, AliMM. Methyl donor micronutrients that modify DNA methylation and cancer outcome. Nutrients, 2019; 11:608.
6.
NasirA, BulloMMH, AhmedZ, et al.Nutrigenomics: Epigenetics and cancer prevention: A comprehensive review. Crit Rev Food Sci Nutr, 2020; 60:1375–1387.
7.
Stypula-CyrusY, DamaniaD, KunteDP, et al.HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure. PLoS One, 2013; 8:64600.
8.
RajendranP, HoE, WilliamsDE, et al.Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics, 2011; 3:4.
9.
Ryan-HarshmanM, AldooriW. Diet and colorectal cancer: Review of the evidence. Can Fam Physician, 2007; 53:1913–1920.
10.
ParkSY, BousheyCJ, WilkensLR, et al.High-quality diets associate with reduced risk of colorectal cancer: Analyses of diet quality indexes in the multiethnic cohort. Gastroenterology, 2017; 153:386–394.
BotmaA, VasenHFA, van DuijnhovenFJB, et al.Dietary patterns and colorectal adenomas in Lynch syndrome. Cancer, 2013; 119:512–521.
13.
ChoYA, LeeJ, OhJH, et al.Dietary inflammatory index and risk of colorectal cancer: A case-control study in Korea. Nutrients, 2016; 8:469.
14.
ShivappaN, ZucchettoA, MontellaM, et al.Inflammatory potential of diet and risk of colorectal cancer: A case-control study from Italy. Br J Nutr, 2015; 114:152–158.
15.
ZhongY, ZhuY, LiQ, et al.Association between Mediterranean diet adherence and colorectal cancer: A dose-response meta-analysis. Am J Clin Nutr, 2020; 111:1214–1225.
16.
ArpónA, Riezu-BojJI, MilagroFI, et al.Adherence to Mediterranean diet is associated with methylation changes in inflammation-related genes in peripheral blood cells. J Physiol Biochem, 2016; 73:445–455.
17.
ArpónA, MilagroFI, RazquinC, et al.Impact of consuming extra-virgin olive oil or nuts within a Mediterranean diet on DNA methylation in peripheral white blood cells within the PREDIMED-navarra randomized controlled trial: A role for dietary lipids. Nutrients, 2018; 10:15.
18.
WillettWC, StampferMJ, ColditzGA, et al.Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med, 1990; 323:1664–1672.
19.
GiovannucciE, RimmE, StampferM, et al.Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res, 1994; 54:2390–2397.
20.
BinghamSA, NoratT, MoskalA, et al.Is the association with fiber from foods in colorectal cancer confounded by folate intake?. Cancer Epidemiol Biomarkers Prev, 2005; 14:1552–1556.
21.
MurphyN, NoratT, FerrariP, et al.Dietary fibre intake and risks of cancers of the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC). PLoS One, 2012; 7:e39361.
22.
GianfrediV, SalvatoriT, VillariniM, et al.Is dietary fibre truly protective against colon cancer? A systematic review and meta-analysis. Int J Food Sci Nutr, 2018; 69:904–915.
23.
MasrulM, NindreaRD. Dietary fibre protective against colorectal cancer patients in Asia: A meta-analysis. Open Access Maced J Med Sci, 2019; 7:1723–1727.
24.
DaïenCI, PingetGV, TanJK, et al.Detrimental impact of microbiota-accessible carbohydrate-deprived diet on gut and immune homeostasis: An overview. Front Immunol, 2017; 8:12.
25.
EatonSB. The ancestral human diet: What was it and should it be a paradigm for contemporary nutrition?. Proc Nutr Soc, 2006; 65:1–6.
26.
WollowskiI, RechkemmerG, Pool-ZobelBL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr, 2001; 73:451S–455S.
27.
HajjarR, RichardCS, SantosMM. The role of butyrate in surgical and oncological outcomes in colorectal cancer. Am J Physiol Gastrointest Liver Physiol, 2021; 320:G601–G608.
28.
QuaglianiD, Felt-GundersonP. Closing America's fiber intake gap: Communication strategies from a food and fiber summit. Am J Lifestyle Med, 2017; 11:80–85.
29.
MichelsKB. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst, 2000; 92:1740–1752.
30.
VogtmannE, XiangYB, LiHL, et al.Fruit and vegetable intake and the risk of colorectal cancer: Results from the Shanghai men's health study. Cancer Causes Control, 2013; 24:1935–1945.
31.
Van DuijnhovenFJB, Bueno-De-MesquitaHB, FerrariP, et al.Fruit, vegetables, and colorectal cancer risk: The European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr, 2009; 89:1441–1452.
32.
TerryP, GiovannucciE, MichelsKB, et al.Fruit, vegetables, dietary fiber, and risk of colorectal cancer. JNCI J Natl Cancer Inst, 2001; 93:525–533.
33.
ParkY, SubarAF, KipnisV, et al.Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP diet and health study. Am J Epidemiol, 2007; 166:170–180.
34.
van PoppelG, VerhoevenDTH, VerhagenH, et al.Brassica vegetables and cancer prevention. Adv Exp Med Biol, 1999; 472:159–168.
35.
KimYI. Folate: A magic bullet or a double edged sword for colorectal cancer prevention?. Gut, 2006; 55:1387–1389.
36.
PufuleteM, Al-GhnaniemR, KhushalA, et al.Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut, 2005; 54:648–653.
37.
JaszewskiR, MisraS, TobiM, et al.Folic acid supplementation inhibits recurrence of colorectal adenomas: A randomized chemoprevention trial. World J Gastroenterol, 2008; 14:4492–4498.
38.
KhosravianiK, WeirHP, HamiltonP, et al.Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut, 2002; 51:195–199.
39.
KimYI, BaikHW, FawazK, et al.Effects of folate supplementation on two provisional molecular markers of colon cancer: A prospective, randomized trial. Am J Gastroenterol, 2001; 96:184–195.
40.
RoswallN, OlsenA, ChristensenJ, et al.Micronutrient intake and risk of colon and rectal cancer in a Danish cohort. Cancer Epidemiol, 2010; 34:40–46.
41.
QinT, DuM, DuH, et al.Folic acid supplements and colorectal cancer risk: Meta-analysis of randomized controlled trials. Sci Rep, 2015; 5:12044.
42.
MoazzenS, DolatkhahR, TabriziJS, et al.Folic acid intake and folate status and colorectal cancer risk: A systematic review and meta-analysis. Clin Nutr, 2018; 37:1926–1934.
43.
AraghiSO, Kiefte-De JongJC, Van DijkSC, et al.Folic acid and Vitamin B12 supplementation and the risk of cancer: Long-term follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial. Cancer Epidemiol Biomarkers Prev, 2019; 28:275–282.
44.
LeeJE, WillettWC, FuchsCS, et al.Folate intake and risk of colorectal cancer and adenoma: Modification by time. Am J Clin Nutr, 2011; 93:817–825.
45.
ColeBF, BaronJA, SandlerRS, et al.Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. J Am Med Assoc, 2007; 297:2351–2359.
46.
WuK, PlatzEA, WillettWC, et al.A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr, 2009; 90:1623–1631.
LoganRFA, GraingeMJ, ShepherdVC, et al.Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology, 2008; 134:29–38.
49.
StevensVL, McCulloughML, SunJ, et al.High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology, 2011; 141:98.e1–105.e1.
50.
MaruvadaP, StoverPJ, MasonJB, et al.Knowledge gaps in understanding the metabolic and clinical effects of excess folates/folic acid: A summary, and perspectives, from an NIH workshop. Am J Clin Nutr, 2020; 112:1390–1403.
51.
HanC, ShinA, LeeJ, et al.Dietary calcium intake and the risk of colorectal cancer: A case control study. BMC Cancer, 2015; 15:966.
52.
ChoE, Smith-WarnerSA, SpiegelmanD, et al.Dairy foods, calcium, and colorectal cancer: A pooled analysis of 10 cohort studies. JNCI J Natl Cancer Inst, 2004; 96:1015–1022.
53.
UccelloM, MalaguarneraG, BasileF, et al.Potential role of probiotics on colorectal cancer prevention. BMC Surg, 2012; 12:S35.
54.
RafterJ, BennettM, CaderniG, et al.Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr, 2007; 85:488–496.
55.
ZhengX, WuK, SongM, et al.Yogurt consumption and risk of conventional and serrated precursors of colorectal cancer. Gut, 2020; 69:970–972.
56.
GiovannucciE. Metabolic syndrome, hyperinsulinemia, and colon cancer: A review. Am J Clin Nutr, 2007; 86:s836–s842.
57.
SieriS, KroghV, AgnoliC, et al.Dietary glycemic index and glycemic load and risk of colorectal cancer: Results from the EPIC-Italy study. Int J Cancer, 2015; 136:2923–2931.
58.
TranTT, NaigamwallaD, OprescuAI, et al.Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology, 2006; 147:1830–1837.
59.
MeyerhardtJA, SatoK, NiedzwieckiD, et al.Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Natl Cancer Inst, 2012; 104:1702–1711.
60.
HuY, DingM, YuanC, et al.Association between coffee intake after diagnosis of colorectal cancer and reduced mortality. Gastroenterology, 2018; 154:916–926.
61.
GuercioBJ, SatoK, NiedzwieckiD, et al.Coffee intake, recurrence, and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance). J Clin Oncol, 2015; 33:3598–3607.
62.
FadeluT, ZhangS, NiedzwieckiD, et al.Nut consumption and survival in patients with stage III colon cancer: Results from CALGB 89803 (Alliance). J Clin Oncol, 2018; 36:1112–1120.
